76
|
233
|
4fe2A |
X-ray structure of saicar synthetase (purc) from streptococcus pneumoniae complexed with air, adp, asp and mg2+ |
76
|
296
|
4fktA |
Crystal structure of the cdk2 in complex with oxindole inhibitor |
114
|
355
|
3r63A |
Structure of erk2 (spe) mutant (s246e) |
86
|
273
|
4fl1A |
Structural and biophysical characterization of the syk activation switch |
73
|
300
|
3r2yA |
Mk2 kinase bound to compound 1 |
79
|
274
|
3r01A |
The discovery of novel benzofuran-2-carboxylic acids as potent pim-1 inhibitors |
71
|
235
|
4fgrA |
X-ray structure of saicar synthetase (purc) from streptococcus pneumoniae complexed with adp and mg2+ |
82
|
298
|
4fkuA |
Crystal structure of the cdk2 in complex with oxindole inhibitor |
84
|
298
|
3r73A |
Cdk2 in complex with inhibitor kvr-1-164 |
85
|
292
|
4fk6A |
Jak1 kinase (jh1 domain) in complex with compound 72 |
93
|
292
|
4fihA |
Catalytic domain of human pak4 with qkftglprqw peptide |
81
|
271
|
3r04A |
The discovery of novel benzofuran-2-carboxylic acids as potent pim-1 inhibitors |
180
|
627
|
4fl3A |
Structural and biophysical characterization of the syk activation switch |
74
|
253
|
4feuA |
Crystal structure of the aminoglycoside phosphotransferase aph(3')-ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone sp600125 |
114
|
346
|
3qywA |
Crystal structure of erk2 in complex with an inhibitor |
129
|
371
|
4fi1A |
Crystal structure of scck2 alpha in complex with atp |
96
|
292
|
4fiiA |
Catalytic domain of human pak4 with rpkplvdp peptide |
79
|
274
|
3r00A |
The discovery of novel benzofuran-2-carboxylic acids as potent pim-1 inhibitors |
75
|
290
|
4fg8A |
Crystal structure of human calcium/calmodulin-dependent protein kinase i 1-315 in complex with atp |
95
|
312
|
4fnxA |
Crystal structure of the apo r1275q anaplastic lymphoma kinase catalytic domain |
73
|
300
|
3r30A |
Mk2 kinase bound to compound 2 |
87
|
298
|
4fklA |
Crystal structure of the cdk2 in complex with thiazolylpyrimidine inhibitor |
80
|
298
|
3r1qA |
Cdk2 in complex with inhibitor kvr-1-102 |
91
|
293
|
4figA |
Catalytic domain of human pak4 |
179
|
627
|
4fl2A |
Structural and biophysical characterization of the syk activation switch |
82
|
267
|
4fevA |
Crystal structure of the aminoglycoside phosphotransferase aph(3')-ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine pp1 |
83
|
298
|
4fkoA |
Crystal structure of the cdk2 in complex with thiazolylpyrimidine inhibitor |
84
|
298
|
4fkqA |
Crystal structure of the cdk2 in complex with oxindole inhibitor |
83
|
298
|
4fkiA |
Crystal structure of the cdk2 in complex with aminopyrazole inhibitor |
82
|
274
|
3qf9A |
Crystal structure of human proto-oncogene serine threonine kinase (pim1) in complex with a consensus peptide and a furan-thiazolidinedione ligand |
106
|
349
|
3queA |
Human p38 map kinase in complex with skepinone-l |
81
|
286
|
3qcxA |
Phosphoinositide-dependent kinase-1 (pdk1) kinase domain with 6-{2-amino-6-[(3r)-3-methyl-4-morpholinyl]-4-pyrimidinyl}-1h-indazol-3-amine |
78
|
295
|
3qquA |
Cocrystal structure of unphosphorylated igf with pyrimidine 8 |
103
|
414
|
3qfvA |
Mrck beta in complex with tpca-1 |
83
|
298
|
3qtuA |
Cdk2 in complex with inhibitor rc-2-132 |
78
|
298
|
3qu0A |
Cdk2 in complex with inhibitor rc-2-38 |
78
|
332
|
3qd2B |
Crystal structure of mouse perk kinase domain |
84
|
270
|
3qrkA |
The crystal structure of human abl1 kinase domain in complex with dp-987 |
78
|
298
|
3qqkA |
Cdk2 in complex with inhibitor l4 |
81
|
298
|
3ql8A |
Cdk2 in complex with inhibitor jws-6-260 |
73
|
298
|
3qzfA |
Cdk2 in complex with inhibitor jws-6-52 |
86
|
298
|
3qhwA |
Structure of a pcdk2/cyclina transition-state mimic |
78
|
298
|
3qtzA |
Cdk2 in complex with inhibitor rc-2-36 |
83
|
298
|
3qqfA |
Cdk2 in complex with inhibitor l1 |
83
|
298
|
3qqjA |
Cdk2 in complex with inhibitor l2 |
82
|
298
|
3qxoA |
Cdk2 in complex with inhibitor kvr-1-84 |
107
|
351
|
3qudA |
Human p38 map kinase in complex with 2-amino-phenylamino-benzophenone |
88
|
286
|
3qcyA |
Phosphoinositide-dependent kinase-1 (pdk1) kinase domain with 4-[2-amino-6-(3-amino-1h-indazol-6-yl)-4-pyrimidinyl]-n-phenyl-2-morpholinecarboxamide |
81
|
298
|
3qtsA |
Cdk2 in complex with inhibitor rc-2-12 |
84
|
298
|
3qqhA |
Cdk2 in complex with inhibitor l2-2 |